会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Targeted drug delivery with a hyaluronan ligand
    • 用透明质酸配体靶向药物递送
    • US06593308B2
    • 2003-07-15
    • US09454811
    • 1999-12-03
    • Francis C. Szoka, Jr.
    • Francis C. Szoka, Jr.
    • A01N4304
    • A61K9/1271A61K47/6911
    • The invention is a drug delivery system of a delivery vehicle having a low molecular weight hyaluronan ligand with an affinity for CD44 receptors. Preferably, the delivery vehicle is a liposome but other suitable delivery vehicles include microspheres, micelles, emulsions, lipid discs, polymers, viral particles and viruses. The systems of the invention may further comprise a drug, which can be any anticancer agent or other therapeutic or diagnostic agent. The invention also comprises methods of delivering a drug to a cell that expresses CD44 by contacting the cell with the drug delivery system. Further methods include treating a patient with cancer and targeting drug delivery to cells that express CD44 by attaching a glycosaminoglycan ligand.
    • 本发明是具有对CD44受体具有亲和力的低分子量透明质酸配体的递送载体的药物递送系统。 优选地,递送载体是脂质体,但是其它合适的递送载体包括微球,胶束,乳剂,脂质盘,聚合物,病毒颗粒和病毒。 本发明的系统还可以包含药物,其可以是任何抗癌剂或其它治疗或诊断剂。 本发明还包括通过使细胞与药物递送系统接触来将药物递送至表达CD44的细胞的方法。 其他方法包括治疗患有癌症的患者,并通过连接糖胺聚糖配体将药物递送靶向表达CD44的细胞。